BEHRENS M KATHLEEN 4
4 · Sarepta Therapeutics, Inc. · Filed Jul 8, 2024
Insider Transaction Report
Form 4
BEHRENS M KATHLEEN
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-07-03−15,000→ 0 totalExercise: $13.90From: 2016-02-27Exp: 2025-02-27→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2024-07-03$13.90/sh+15,000$208,500→ 191,839 total
Holdings
- 10,000(indirect: By Trust)
Common Stock